Filing Details
- Accession Number:
- 0001181431-13-043067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-06 17:00:01
- Reporting Period:
- 2013-08-02
- Filing Date:
- 2013-08-06
- Accepted Time:
- 2013-08-06 17:00:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1529371 | Cheryl Cohen | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-08-02 | 25,000 | $9.61 | 50,439 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-08-02 | 25,000 | $59.31 | 25,439 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-08-02 | 25,000 | $0.00 | 25,000 | $9.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
350,000 | 2021-09-15 | No | 4 | D | Direct |
Footnotes
- The shares were sold pursuant to a 10b5-1 Plan dated June 3, 2013.
- The shares were sold at prices ranging from $59.10 to $59.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) shall vest on September 15, 2012, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) shall vest of the first day of each full month thereafter.